EK
Therapeutic Areas
GPN Vaccines Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Gamma‑PN | Pneumococcal disease | Phase 1b |
Leadership Team at GPN Vaccines
TH
Tim Hirst, PhD
Chief Executive Officer
BF
Bruce Forrest, MD, PhD, MBA
Executive Chief Scientific Officer
LG
Lauren Giorgio, PhD, GAICD
Chief Operating Officer
PR
Paul Rolan, MBBS, MD, FRACP
Chief Medical Officer
JS
James Selkirk, FCA, MAICD
Chief Financial Officer